Print page content Print
Increase text size Decrease text size
Text Size

DRAXXIN®

(tulathromycin) Injectable Solution

10001435

For dairy calves up to 20 months of age, DRAXXIN is the only anti-infective approved for the treatment of BRD caused by all four major pathogens, including Mycoplasma bovis, and pink eye. It also lends itself to greater efficiency options with its label claim for the treatment of foot rot.

Collapse All
  • DRAXXIN® (tulathromycin) Injectable Solution is a unique, novel treatment that delivers:

    Superior efficacy to treat BRD when compared with Baytril®, Nuflor® and Micotil® in field studies.1,2,3,6

    Convenient, full course of therapy in a single dose.

    Effectiveness against the four major BRD pathogens.

    Mannheimia (Pasteurella) haemolytica

    Pasteurella multocida

    Histophilus somni (Haemophilus somnus)

    Mycoplasma bovis

    Excellent first BRD treatment response.1,2,3,6

    Remarkably lower mortalities and chronics due to BRD. 1,2,3

    Effective control of BRD in cattle at high risk of developing BRD.3

    1. Skogerboe TL, Rooney KA, Nutsch RG, Weigel DJ, Gajewski K, Kilgore WR.
      Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. Vet Ther 2005; 6(2): 180-196.
    2. Nutsch RG, Skogerboe TL, Rooney KA, Weigel DJ, Gajewski K, Lectenberg KF.
      Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle. Vet Ther  2005; 6(2): 167-179.
    3. Rooney KA, Nutsch RG, Skogerboe TL, Weigel DJ, Gajewski K, Kilgore WR.
      Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. Vet Ther 2005; 6(2): 154-166.
    4. Nowakowski MA, Inskeep P, Risk J, et al.
      Pharmacokentics and lung tissue concentration of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther  2004; 5:60-75.
    5.  Evans NA. Tulathromycin: An overview of a new triamilide antibiotic for livestock respiratory disease. Vet Ther  2005; 6(2): 83-95.
  • The Single Dose Convenience You Want

    • Convenient, low dose volume (1 mL/40 kg, or 1.1 mL/100 lb, 100 mg of tulathromycin/mL) and easily syringeable.
    • Single dose SC (under the skin) injection in the neck of cattle.
    • Packaged in 100, 250 and 500 mL glass vials.
    • Ready-to-use, clear aqueous solution.
    • Highly syringeable.
  • Efficacy of DRAXXIN®, followed by 7-,10-, or 14-day post-treatment intervals, against naturally occurring bovine respiratory disease

    Efficacy of DRAXXIN® (tulathromycin) Injectable Solution for treatment of experimentally induced Mycoplasma bovis respiratory infection in calves

Important Safety Information

Draxxin has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. Effects on reproductive performance, pregnancy and lactation have not been determined.

Prescribing Information

CONTACT US

1-888-963-8471

We are Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2020 Zoetis Services LLC. All rights reserved.